2016
DOI: 10.1097/ijg.0000000000000450
|View full text |Cite
|
Sign up to set email alerts
|

Long-term Follow-up of a Case of Gold Shunt Surgery for Refractory Silicone Oil–induced Glaucoma

Abstract: Purpose:To report the first case of gold shunt surgery for treatment of silicone oil–induced refractory glaucoma in a tertiary care academic center, with 5-year follow-up.Design:The study design is a case report.Participants:The participant was a patient who underwent gold shunt surgery.Methods:Institutional Research Ethics Board approval for the study was obtained. A diabetic patient was referred for refractory glaucoma with a history of proliferative diabetic retinal detachment, and surgery with silicone oil… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
0
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 18 publications
0
0
0
Order By: Relevance
“…Supraciliary shunts, such as the Cypass, which is no longer in use, and the gold micro shunts are attractive options that have proved effective in single case reports in SO-associated glaucoma [61,62]. However, their use in this particular setting has not been well explored.…”
Section: Supraciliary Shuntsmentioning
confidence: 99%
See 1 more Smart Citation
“…Supraciliary shunts, such as the Cypass, which is no longer in use, and the gold micro shunts are attractive options that have proved effective in single case reports in SO-associated glaucoma [61,62]. However, their use in this particular setting has not been well explored.…”
Section: Supraciliary Shuntsmentioning
confidence: 99%
“…However, their use in this particular setting has not been well explored. Moreover, their use has been associated with endothelial cell loss and with fibrosis and encapsulation [62] and the consequences of potential migration of SO in the suprachoroidal space are unknown [61]. More studies are required to establish their efficacy and safety profile.…”
Section: Supraciliary Shuntsmentioning
confidence: 99%